Ein Cannabis-Gewächshaus. (Symbolbild)
Freitag, 15.02.2019 12:01 von | Aufrufe: 237

/R E P E A T -- Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results: Gross Sales of $98M; Net Revenue hits record $83M/

Ein Cannabis-Gewächshaus. (Symbolbild) ©unsplash.com

PR Newswire

  • Cannabis shipments totaled 10,102 kilograms and kilogram equivalents.
  • Net income of $74.9 million, including changes in fair values of financial liabilities included in Other Income.
  • Closed the previously announced $5 billion investment by Constellation Brands Inc and began putting that capital to work for shareholders with key acquisitions of Storz & Bickel and the assets of ebbu Inc.
  • Expanded to new markets including United Kingdom and Peru, and announced intention to establish operations in New York State, marking the Company's entry into the US hemp market.
  • Intellectual property portfolio grew to 32 issued patents and over 140 patent applications, covering a range of target areas from technology to genetics to clinical formulations.

SMITHS FALLS, ON, Feb. 14, 2019 /PRNewswire/ - Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or "the Company") today released its consolidated financial results for the third quarter fiscal 2019 ended December 31, 2018.  All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.

 

Third Quarter Fiscal 2019 Operational and Financial Highlights






Q3 2019

Q3 2018

% Change

Net revenue (millions)


ARIVA.DE Börsen-Geflüster

Kurse

9,505 $
-2,31%
Canopy Growth Corp Chart

$83.0

$21.7

282%

Kilograms and kilogram equivalents sold

10,102

2,330

334%

Average Selling Price per gram - Recreational

$6.96

-

NM

Average Selling Price per gram - Canadian Medical

$9.77

$8.21

19%

Average Selling Price per gram - International Medical

$13.28

$12.61

5%

Average Selling Price per gram

$7.33

$8.30

-12%

Inventory & Biological Assets (millions)

$216

$108

100%

Kilograms harvested (kilograms)

7,556

7,961

-5%

Cash, cash equivalents and marketable securities (millions)

$4,915

$429

1046%

NM = Not Meaningful




 

Third Quarter Fiscal 2019 Revenue Highlights






Q3 2019

Q3 2018

% Change

Canadian Recreational Cannabis Gross Revenue - Business to Business

$60.1

-

NM

Canadian Recreational Cannabis Gross Revenue - Business to Consumer

$11.5

-

NM

Canadian Recreational Cannabis Revenue - Subtotal

$71.6

-

NM

Canadian Medical Cannabis Gross Revenue

$15.9

$19.3

-18%

International Medical Cannabis Gross Revenue

$2.7

$1.0

170%

Medical Revenue - Subtotal

$18.6

$20.3

-8%

Other Revenue

$7.5

$1.4

436%

Total Gross Revenue

$97.7

$21.7

350%

Less Excise Taxes

$14.7

-

NM

Net Revenue

$83.0

$21.7

282%

NM = Not Meaningful




 

Third Quarter Fiscal 2019 Product Sales Highlights





Product Sales (Kilograms & kilogram equivalents)

Q3 2019

Q3 2018

% Change

Canadian Recreational Cannabis - Business to Business

7,381

0

Werbung

Mehr Nachrichten zur Canopy Growth Corp Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News